# Plasma Copeptin in Response to Oral Urea in Healthy Adults and Patients With Polyuria-polydipsia Syndrome

> **NCT05890690** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 48 (actual)

## Conditions studied

- Arginine Vasopressin Deficiency
- Primary Polydipsia

## Interventions

- **DIAGNOSTIC_TEST:** Urea
- **DIAGNOSTIC_TEST:** Placebo

## Key facts

- **NCT ID:** NCT05890690
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-02
- **Primary completion:** 2024-06-24
- **Final completion:** 2024-06-24
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05890690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05890690, "Plasma Copeptin in Response to Oral Urea in Healthy Adults and Patients With Polyuria-polydipsia Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05890690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*